On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Chan‐Young Ock

ResearcherPublications, citations & collaboration network

Chan‐Young Ock is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Chan‐Young Ock have?

ScholarIQindexed works

Chan‐Young Ock has 369 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Chan‐Young Ock have?

ScholarIQcitation count

Chan‐Young Ock has 2,293 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Chan‐Young Ock?

ScholarIQh-index

Chan‐Young Ock has an h-index of 24 in OpenAlex.

What is the i10-index of Chan‐Young Ock?

ScholarIQi10-index

Chan‐Young Ock has an i10-index of 44 in OpenAlex.

What is the ORCID of Chan‐Young Ock?

ScholarIQorcid

The ORCID for Chan‐Young Ock is on the source record.

What is the OpenAlex record for Chan‐Young Ock?

ScholarIQopenalex

The OpenAlex for Chan‐Young Ock is on the source record.

What are the most-cited papers on Chan‐Young Ock?

ScholarIQmost cited works
Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer
Sehhoon Park, Chan‐Young Ock, Hyojin Kim, Sérgio Pereira, Seonwook Park, Minuk Ma, Sangjoon Choi, Seokhwi Kim, Seunghwan Shin, Brian Jaehong Aum, Kyunghyun Paeng, Donggeun Yoo, Hongui Cha, Sunyoung Park, Koung Jin Suh, Hyun Ae Jung, Se Hyun Kim, Yu Jung Kim, Jong‐Mu Sun, Jin-Haeng Chung, Jin Seok Ahn, Myung‐Ju Ahn, Jong Seok Lee, Keunchil Park, Sang Yong Song, Yung‐Jue Bang, Yoon‐La Choi, Tony Mok, Se‐Hoon Lee
Journal of Clinical Oncology. 2022290 CitationsOPEN ACCESS
Artificial Intelligence in Breast Cancer Diagnosis and Personalized Medicine
Jong Seok Ahn, Sangwon Shin, Su‐A Yang, Eun Kyung Park, Ki Hwan Kim, Soo Ick Cho, Chan‐Young Ock, Seokhwi Kim
Journal of Breast Cancer. 2023203 CitationsOPEN ACCESS
Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With <i>EGFR</i>- or <i>ALK</i>-Rearranged or Translocated Non–Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)
Sehhoon Park, Tae Min Kim, Ji‐Youn Han, Gyeong‐Won Lee, Byoung Yong Shim, Yun‐Gyoo Lee, Sang‐We Kim, Il Hwan Kim, Suee Lee, Yu Jung Kim, Ji Hyun Park, Sang-Gon Park, Ki Hyeong Lee, Eun Joo Kang, Ju Won Kim, Seong Hoon Shin, Chan‐Young Ock, Byung‐Ho Nam, Jaebong Lee, Hyun Ae Jung, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Myung‐Ju Ahn
Journal of Clinical Oncology. 2023172 CitationsOPEN ACCESS
Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer
Sehui Kim, Ji-Young Jang, Jaemoon Koh, Dohee Kwon, Young A Kim, Jin Chul Paeng, Chan‐Young Ock, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dae Seog Heo, Doo Hyun Chung, Yoon Kyung Jeon
Journal of Experimental & Clinical Cancer Research. 2019104 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial